Professional Documents
Culture Documents
Course Code: BP402T Course Title: Medicinal Chemistry I
Course Code: BP402T Course Title: Medicinal Chemistry I
Course Leader:
Mrs. M. K. Yuvapriya (yuvapriya.py.ph@msruas.ac.in)
1
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Lecture No. 17
Adrenergic agents 4
2
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic
agents 4
3
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Intended learning outcomes
4
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Contents
5
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents
• Adrenergic blockers are also called as antiadrenergic
drugs or sympatholytics
• Adrenergic blocking agents prevent the response of
effector organs to endogenous as well as exogenous
adrenaline and noradrenaline
• These drugs block the actions of adrenergic drugs at
alpha (α) or beta (β) adrenergic receptors
• Useful in medicine, particularly in the treatment of
cardiovascular diseases
6
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents
Mechanism of Action of α -Adrenergic Blockers
• α -Adrenergic receptor response in clinical relevance include α1
receptor mediated contraction of arterial and venous smooth
muscle.
• α2 adrenergic receptors are involved in suppressing sympathetic
output, increasing vagal tone, facilitating platelet aggregation,
inhibiting the release of norepinephrine, and acetylcholine
• from nerve endings.
• Blockade of α1 receptors inhibits vasoconstriction induced by
endogenous catecholamines
• Vasodilatation may occur in both arteriolar resistance vessels and
veins.
7
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents
Mechanism of Action of α -Adrenergic Blockers
• α2 receptor regulates both central and peripheral sympathetic
neurons.
• Acceleration of presynaptic α2 receptors inhibits the
norepinephrine release.
• In some vascular beds, these drugs promote vasodilatation
through the release of nitric oxide (endothelial relaxing factor).
• Phenoxybenzamine inhibits the uptake of catecholamine from the
nerve terminals.
• Phentolamine and tolazoline are competitive α adrenergic
antagonists and block the receptor for 5-HT and it causes the
release of histamine from the mast cells, which is a potent
vasodilator.
8
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents
Mechanism of Action of β-Adrenergic Receptor Blockers
• β adrenergic receptor antagonists slow the heart rate and decrease
the myocardial contractility, these prolongs the systolic conduction
and disturbs the ventricular fibres.
• Dimensions of the ventricle is decreased, oxygen consumption is
decreased, and thereby decreases the heart rate and aortic pressure.
• In blood vessels, these drugs reduces the noradrenaline release from
the sympathetic terminals and decrease the renin from kidney due to
the blockade of β receptors
9
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents: Classification
d. Quinazolines:
i.Prazosin
ii.Terazosin
iii.Doxazosin
e. Miscellaneous
i.Indoramine
ii.Yohimbine
iii.Chlorpromazine
11
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Adrenergic blocking agents: Classification
II. Beta-receptor blocking agents
a. β-Blockers with membrane stabilizing activity and intrinsic
sympathomimetic property:
i.Oxprenalol
ii.Pindalol
b. Specifi c β-blockers:
i.Timolol
ii.Nodalol
c. β-blockers with membrane stabilizing activity
i.Propranolol
d. β-blockers with cardio selective action
i. Acebutolol
ii. Atenolol
iii.Metaprolol
12
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
14
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Phentolamine:
Phenoxybenzamine (Dibenzyline)
• Phenoxybenzamine is a synthetic, dibenzamine alpha adrenergic
antagonist with antihypertensive and vasodilatory properties.
• Phenoxybenzamine non-selectively and irreversibly blocks the
postsynaptic alpha-adrenergic receptor in smooth muscle, thereby
preventing vasoconstriction, relieving vasospasms, and decreasing
peripheral resistance.
• Reflex tachycardia may occur and may be enhanced by blockade of
alpha-2 receptors which enhances norepinephrine release.
• Phenoxybenzamine is reasonably anticipated to be a human
carcinogen.
• Phenoxybenzamine is an aromatic amine.
16
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Phenoxybenzamine (Dibenzyline)
17
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Phenoxybenzamine (Dibenzyline)
19
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
20
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Dihydroergotamine
• Dihydroergotamine is an Ergotamine Derivative. The chemical
classification of dihydroergotamine is Ergotamines.
• Ergot alkaloids are widely used for therapy of acute migraine
headaches and include ergotamine and dihydroergotamine, both of
which act by causing vasoconstriction of the carotid artery beds.
• Ergot alkaloids have multiple side effects, but have little effect on the
liver and have not been clearly linked to instances of clinically
apparent acute liver injury.
21
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Dihydroergotamine
• A 9,10alpha-dihydro derivative of ERGOTAMINE.
• It is used as a vasoconstrictor, specifically for the therapy of
MIGRAINE DISORDERS.
22
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Methysergide
• An ergot derivative that is a congener of LYSERGIC ACID
DIETHYLAMIDE
• It antagonizes the effects of serotonin in blood vessels and
gastrointestinal smooth muscle, but has few of the properties of
other ergot alkaloids
• Methysergide is used prophylactically in migraine and other vascular
headaches and to antagonize serotonin in the carcinoid syndrome
• Chemically it is (6aR,9R)-N-[(2S)-1-hydroxybutan-2-yl]-4,7-dimethyl-
6,6a,8,9-tetrahydroindolo[4,3-fg]quinoline-9-carboxamide is an
ergoline alkaloid.
23
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Alpha adrenergic blocker: Drug Profile
Methysergide
24
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Summary
25
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
Disclaimer
• Some of the contents of this subject has been sourced from web
sources and e-books.
• REFERENCES -
– www.google.com
– en.wikipedia.org
26
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences
THANK YOU
27
Faculty of Pharmacy ©M. S. Ramaiah University of Applied Sciences